These were the worst performing shares on the ASX 200 last week

A2 Milk Company Ltd (ASX:A2M) and Mesoblast limited (ASX:MSB) shares were among the worst performers on the ASX 200 last week…
The post These were the worst performing shares on the ASX 200 last week appeared first on Motley Fool Australia. –

Share price plummet

Last week was a tough one for the S&P/ASX 200 Index (ASX: XJO). The benchmark index lost 2.9% over the five days to end at 5,791.5 points.

While a number of shares dropped lower with the market last week, some stood out with particularly large declines.

Four shares that tumbled notably lower last week are listed below. Here’s why they were the worst performers on ASX 200 over the period:

Mesoblast limited (ASX: MSB)

The Mesoblast share price was the worst performer on the ASX 200 last week by some distance with a sizeable 35% decline. Investors were hitting the sell button on Friday after the biotechnology company revealed that the US FDA has not approved its remestemcel-L (RYONCIL) treatment for paediatric patients with steroid-refractory acute graft versus host disease (SR-aGVHD). Instead, the FDA has requested that Mesoblast undertake at least one additional randomised, controlled study in adults and/or children. This is to provide further evidence of the effectiveness of remestemcel-L for SR-aGVHD.

A2 Milk Company Ltd (ASX: A2M)

The A2 Milk share price was well and truly out of form last week with an 18.5% decline. Investors were selling the infant formula and fresh milk company’s shares after it updated its outlook for FY 2021. According to the release, a2 Milk has been experiencing weakness in the daigou channel following lockdowns and international travel restrictions. As a result, management expects its first half sales to be down 3.9% to 10.1% compared to the prior corresponding period.

Blackmores Limited (ASX: BKL)

The Blackmores share price was the next worst performer with a decline of 11.1% over the five days. This decline appears to have been driven by concerns that it too could be impacted by weakness in the daigou channel during the pandemic. This could mean the health supplements company’s recovery takes longer than expected.

NRW Holdings Limited (ASX: NWH)

The NRW share price was out of form and dropped 9.6% lower. Last week the mining services company announced that attempts to place Gascoyne Resources into liquidation failed in the Federal Court. Gascoyne is currently in voluntary administration, with NRW involved in the recapitalisation of the company. NRW was a creditor to Gascoyne and is owed $32.7 million.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk and Blackmores Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post These were the worst performing shares on the ASX 200 last week appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!